Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast agents in neuroimaging

S E Byrd1, C F Darling, E Allen

  • 1Department of Radiology, Children's Memorial Hospital, Chicago, Illinois.

Neuroimaging Clinics of North America
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartphone-based hyperspectral imaging for ice sheet and proglacial applications in South-West Greenland.

The Science of the total environment·2024
Same author

Is being a victim of bullying or cyberbullying in secondary school associated with subsequent risk-taking behavior in adolescence? A longitudinal study in secondary schools.

Journal of adolescence·2022
Same author

Feasibility and acceptability of a whole-school social-marketing intervention to prevent unintended teenage pregnancies and promote sexual health: evidence for progression from a pilot to a phase III randomised trial in English secondary schools.

Pilot and feasibility studies·2022
Same author

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients.

Arthritis care & research·2017
Same author

Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa.

Clinical pharmacology and therapeutics·2017
Same author

Impact of baseline vitamin B12 status on the effect of vitamin B12 supplementation on neurologic function in older people: secondary analysis of data from the OPEN randomised controlled trial.

European journal of clinical nutrition·2017
Same journal

State-of-the-Art Epilepsy Imaging: Improving Tools for Epileptogenic Lesion Detection and Treatment.

Neuroimaging clinics of North America·2026
Same journal

Imaging of Epilepsy.

Neuroimaging clinics of North America·2026
Same journal

Implanted Devices for Management of Drug-Resistant Epilepsy: Background and MR Imaging Considerations.

Neuroimaging clinics of North America·2026
Same journal

Imaging of Epilepsy Surgery, Minimally Invasive Techniques, and Neuromodulation.

Neuroimaging clinics of North America·2026
Same journal

Neuroimaging and the Epilepsy Journey.

Neuroimaging clinics of North America·2026
Same journal

Clinical Functional Magnetic Resonance Imaging in Epilepsy.

Neuroimaging clinics of North America·2026
See all related articles

Researchers continue to seek improved contrast agents to minimize adverse reactions. The ideal agent must be safe, effective, stable, and cost-efficient for medical imaging.

Area of Science:

  • Medical Imaging
  • Radiology
  • Pharmaceutical Science

Background:

  • Contrast agents are crucial for diagnostic imaging.
  • Current contrast agents can cause adverse reactions and side effects.
  • There is an ongoing need to enhance the safety and efficacy of these agents.

Purpose of the Study:

  • To define the characteristics of an ideal contrast agent.
  • To highlight areas for improvement in existing contrast media.

Main Methods:

  • Literature review and analysis of desired properties for contrast agents.
  • Evaluation of safety, efficacy, and physicochemical characteristics.

Main Results:

  • An ideal contrast agent requires a balance of multiple properties.

Related Experiment Videos

  • Key attributes include efficacy, safety, water solubility, stability, biological inertness, low viscosity, physiological osmolality, selective renal excretion, and affordability.

    • Conclusions:

    • No current contrast agent perfectly meets all ideal criteria.
    • Continued research and development are necessary to achieve an optimal contrast agent for medical applications.